Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
Critical Reviews™ in Immunology
Factor de Impacto: 1.352 Factor de Impacto de 5 años: 3.347 SJR: 0.657 SNIP: 0.55 CiteScore™: 2.19

ISSN Imprimir: 1040-8401
ISSN En Línea: 2162-6472

Volumes:
Volumen 39, 2019 Volumen 38, 2018 Volumen 37, 2017 Volumen 36, 2016 Volumen 35, 2015 Volumen 34, 2014 Volumen 33, 2013 Volumen 32, 2012 Volumen 31, 2011 Volumen 30, 2010 Volumen 29, 2009 Volumen 28, 2008 Volumen 27, 2007 Volumen 26, 2006 Volumen 25, 2005 Volumen 24, 2004 Volumen 23, 2003 Volumen 22, 2002 Volumen 21, 2001 Volumen 20, 2000 Volumen 19, 1999 Volumen 18, 1998 Volumen 17, 1997 Volumen 16, 1996 Volumen 15, 1995 Volumen 14, 1994

Critical Reviews™ in Immunology

DOI: 10.1615/CritRevImmunol.2013010019
pages 15-39

T-Cell Immunity to Influenza A Viruses

Emma J. Grant
Department of Microbiology and Immunology, The University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Victoria 3010, Australia
Li Chen
Department of Clinical Microbiology and Immunology, College of Medical Laboratory Science, Third Military Medical University, Chongqing, PR China; Department of Biochemistry, La Trobe University, Bundoora, Australia
Sergio Quinones-Parra
Department of Microbiology and Immunology, The University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Victoria 3010, Australia
Ken Pang
Inflammation Division, The Walter and Eliza Hall Institute for Medical Research, Parkville, Australia; Department of Paediatrics, University of Melbourne, Parkville, Australia
Katherine Kedzierska
Department of Microbiology and Immunology, The University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Victoria 3010, Australia
Weisan Chen
Department of Biochemistry, La Trobe University, Bundoora, Australia

SINOPSIS

Influenza infection remains a global threat to human health. Influenza viruses are normally controlled by antibodies specific for the surface glycoproteins hemagglutinin (HA) and neuraminidase (NA). Standard influenza vaccines are aimed at inducing these antibodies, but they must be administered annually and can be rendered ineffective since different strains circulate from year to year and vary considerably in their individual HA and NA profiles. Influenza-specific T cells have been shown to be protective in animal models and typically recognize the more conserved internal influenza proteins. Improving our understanding of influenza-specific T-cell responses, including immunodominance, specific epitope sequences, strain-related epitope variation, host/virus interaction, and the balance between immunity versus immunopathology, will be important to improve future T-cell-based vaccines, which promise broader strain coverage and longer-lasting protection than current standard vaccines.

PALABRAS CLAVE: influenza, T cell, epitope, HLA, vaccine

Articles with similar content:

Abstract of "Ethical Challenges with the Development of Biotechnology-Derived Allergy Therapeutics"
Journal of Long-Term Effects of Medical Implants, Vol.18, 2008, issue 1
Jason Behrmann
Role of the VlsE Lipoprotein in Immune Avoidance by the Lyme Disease Spirochete Borrelia burgdorferi
Forum on Immunopathological Diseases and Therapeutics, Vol.7, 2016, issue 3-4
Troy Bankhead
Sovereign Wrongs: Ethics in the Governance of Pathogenic Genetic Resources
Ethics in Biology, Engineering and Medicine: An International Journal, Vol.3, 2012, issue 1-3
Catherine Rhodes
HSV-1 Infection: Role of Viral Proteins and Cellular Receptors
Critical Reviews™ in Eukaryotic Gene Expression, Vol.29, 2019, issue 5
Muhammad Shahid, Saima Younas, Muhammad Idrees, Ayesha Vajeeha, Samia Afzal, Iram Amin, Muhammad Umer Khan, Rabia Nawaz
Measles Virus Infection and Vaccination: Potential Role in Chronic Illness and Associated Adverse Events
Critical Reviews™ in Immunology, Vol.24, 2004, issue 2
Vera S. Byers, Ronald C. Kennedy, John J. Marchalonis